Biocon Limited (BIOCON.BO)
INR 348.0
(0.01%)
INR 348.0
(0.01%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 147.55 Billion | 109.34 Billion | 80.24 Billion | 70.07 Billion | 61.44 Billion | 53.81 Billion |
| Cost of Revenue | 55.82 Billion | 36.66 Billion | 27.23 Billion | 22.45 Billion | 19.91 Billion | 18.98 Billion |
| Gross Profit | 91.73 Billion | 72.67 Billion | 53.01 Billion | 47.62 Billion | 41.53 Billion | 34.82 Billion |
| Operating Expenses | 40.9 Billion | 58.53 Billion | 42.33 Billion | 41.57 Billion | 34.46 Billion | 28.02 Billion |
| Selling, General and Administrative Expenses | 28.52 Billion | 4.86 Billion | 4.3 Billion | 4.88 Billion | 4.17 Billion | 3.94 Billion |
| Research and Development Expenses | 12.37 Billion | 7.03 Billion | 3.1 Billion | 5.31 Billion | 4.32 Billion | 2.45 Billion |
| Other Expenses | - | 2.17 Billion | 1.19 Billion | 3.57 Billion | 3.5 Billion | 2.73 Billion |
| Cost and Expenses | 96.72 Billion | 95.2 Billion | 69.56 Billion | 64.02 Billion | 54.38 Billion | 47.01 Billion |
| Operating Income | 50.83 Billion | 19.52 Billion | 12.06 Billion | 9.62 Billion | 9.99 Billion | 9.03 Billion |
| Interest Expense | 9.74 Billion | 4.19 Billion | 676 Million | 577 Million | 649 Million | 705 Million |
| Income Tax Expense | 2.27 Billion | 2.54 Billion | 2.11 Billion | 2.21 Billion | 3.15 Billion | 2.12 Billion |
| Earnings before Tax | 16.09 Billion | 8.97 Billion | 9.83 Billion | 10.67 Billion | 12.14 Billion | 12.14 Billion |
| Net Income | 10.22 Billion | 4.62 Billion | 6.48 Billion | 7.4 Billion | 7.48 Billion | 9.05 Billion |
| Earnings Per Share Basic | 8.55 | 3.88 | 5.44 | 6.24 | 6.32 | 7.65 |
| Earnings Per Share Diluted | 8.54 | 3.87 | 5.42 | 6.19 | 6.30 | 7.60 |
| Weighted Average Shares Outstanding | 1.19 Billion | 1.19 Billion | 1.19 Billion | 1.18 Billion | 1.18 Billion | 1.18 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.19 Billion | 1.19 Billion | 1.19 Billion | 1.19 Billion | 1.18 Billion | 1.19 Billion |
| Gross Margin | 0.62 | 0.66 | 0.66 | 0.68 | 0.68 | 0.65 |
| EBIT Margin | 0.28 | 0.23 | 0.24 | 0.24 | 0.29 | 0.28 |
| Profit Margin | 0.07 | 0.04 | 0.08 | 0.11 | 0.12 | 0.17 |
| EBITDA | 41.52 Billion | 25.96 Billion | 20.71 Billion | 19.19 Billion | 18.32 Billion | 17.32 Billion |
| Earnings Before Tax Margin | 0.34 | 0.18 | 0.15 | 0.14 | 0.16 | 0.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 35.45 Billion | 34.32 Billion | 147.55 Billion | 39.17 Billion | 35.48 Billion | 34.62 Billion |
| Cost of Revenue | 11.82 Billion | 23.11 Billion | 90.47 Billion | 24.04 Billion | 12.31 Billion | 11.27 Billion |
| Gross Profit | 23.62 Billion | 11.21 Billion | 57.08 Billion | 15.12 Billion | 23.16 Billion | 23.35 Billion |
| Operating Expenses | 21.41 Billion | 9.06 Billion | 39.78 Billion | 10.03 Billion | 18.04 Billion | 19.86 Billion |
| Selling, General and Administrative Expenses | 7.13 Billion | 6.78 Billion | - | 10.03 Billion | 7.46 Billion | 7.11 Billion |
| Research and Development Expenses | 2.64 Billion | 2.28 Billion | - | 737 Million | -13 Million | 2.64 Billion |
| Other Expenses | 21.41 Billion | 1.09 Billion | 9.49 Billion | 1.22 Billion | 5.65 Billion | 1.61 Billion |
| Cost and Expenses | 33.23 Billion | 32.17 Billion | 130.25 Billion | 34.08 Billion | 30.36 Billion | 31.13 Billion |
| Operating Income | 2.21 Billion | 2.15 Billion | 17.29 Billion | 5.08 Billion | 5.12 Billion | 3.52 Billion |
| Interest Expense | 2.25 Billion | 2.36 Billion | 9.74 Billion | 2.27 Billion | 2.66 Billion | 2.47 Billion |
| Income Tax Expense | 713 Million | 2.83 Billion | 2.27 Billion | 961 Million | 549 Million | 416 Million |
| Earnings before Tax | 984 Million | 11.45 Billion | 16.09 Billion | 3.21 Billion | 8.08 Billion | 2.14 Billion |
| Net Income | -160 Million | 6.59 Billion | 10.22 Billion | 1.35 Billion | 6.6 Billion | 1.25 Billion |
| Earnings Per Share Basic | -0.13 | 5.49 | - | 1.13 | 5.50 | 1.05 |
| Earnings Per Share Diluted | -0.13 | 5.49 | - | 1.13 | 5.50 | 1.05 |
| Weighted Average Shares Outstanding | 1.23 Billion | 1.2 Billion | 1.19 Billion | 1.19 Billion | 1.2 Billion | 1.2 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.23 Billion | 1.2 Billion | 1.19 Billion | 1.19 Billion | 1.2 Billion | 1.2 Billion |
| Gross Margin | 0.67 | 0.33 | 0.39 | 0.39 | 0.65 | 0.67 |
| EBIT Margin | 0.21 | 0.18 | - | 0.23 | 0.41 | 0.25 |
| Profit Margin | -0.00 | 0.19 | 0.07 | 0.03 | 0.19 | 0.04 |
| EBITDA | 7.43 Billion | 6.2 Billion | - | 9.15 Billion | 14.68 Billion | 8.75 Billion |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.12 | 0.13 | 0.14 | 0.10 |
0JSP
NTRBW
HOFBF
PALI
CACO
016610